Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 54 min ago
PreprintAll rights reservedmedRxiv

Modelled mortality benefits of reducing fibrinolysis resistance in sepsis: integrating observational and ex vivo data

  1. 1Intensive Care Unit, Liverpool Hospital, Liverpool, Australia

Related

  1. Fibrinolysis resistance in sepsis assessed by serial beside viscoelastometry is associated with plasma protein profiles and organ-failure severity: a prospective observational study
    L. Coupland, M. Self, E. Suryana +8
    medRxivPreprintAll rights reservedFull textEpidemiology & public healthmedRxiv
  2. TyG-ABSI and TyG-WWI as insulin-resistance body shape markers of mortality in middle-aged and older adults within the cardiovascular-kidney-metabolic framework: A multi-cohort observational study with external survival-model validation.
    Fangping Xiao, Hui Guo, Lei Wang +2
    MedicinePeer-reviewedCC BY-NCFull textEndocrinology & metabolismEurope PMC
  3. Safety and Preliminary Clinical Outcomes of Integrating Engineered Synthetic Lipid Vesicles (Biosomes) in a Skin Booster Protocol: A Prospective Observational Study
    Antonella Franceschelli, Alessandra Procaccini, Deborah Subissati +3
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Favourable discharge after cardiac arrest across APACHE IVa-predicted hospital mortality: a multicentre observational study
    A. Gorenshtein, A. Srour, Y. Adiniaev +3
    medRxivPreprintAll rights reservedFull textGeneral medicinemedRxiv
  5. Documented preoperative statin exposure and short-term mortality after aortic valve replacement: a multicohort observational study
    Min Woo Kang, Suk Ho Sohn, Jae Woong Choi +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textCardiovascular medicineCrossref
BibTeX
@misc{coupland2026modelled,
  title = {{Modelled mortality benefits of reducing fibrinolysis resistance in sepsis: integrating observational and ex vivo data}},
  author = {L. Coupland and M. Self and E. Suryana and R. Law and P. Crispin and C. Keragala and S. Frost and D. Rabbolini and P. Moore and R. Medcalf and A. Aneman},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.24.26366402},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.24.26366402v1},
}
RIS
TY  - UNPB
TI  - Modelled mortality benefits of reducing fibrinolysis resistance in sepsis: integrating observational and ex vivo data
AU  - L. Coupland
AU  - M. Self
AU  - E. Suryana
AU  - R. Law
AU  - P. Crispin
AU  - C. Keragala
AU  - S. Frost
AU  - D. Rabbolini
AU  - P. Moore
AU  - R. Medcalf
AU  - A. Aneman
PY  - 2026
DA  - 2026/10/24
PB  - medRxiv
DO  - 10.64898/2026.10.24.26366402
UR  - https://www.medrxiv.org/content/10.64898/2026.10.24.26366402v1
ER  -